Cost-effectiveness of susceptibility-guided therapy under varying rates of clarithromycin resistance
Background: With resistance of Helicobacter polyri to antibiotics reaching alarming levels worldwide, the Maastricht VI/Florence consensus report recommended that susceptibility tests are routinely performed to improve cure rates, even before prescribing first-line treatment. However, the routine us...
Saved in:
| Main Authors: | Shihan Xu, Xianzhu Zhou, Yiqi Du |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | The Lancet Regional Health. Western Pacific |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S266660652400364X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clarithromycin Resistance Rates of Helicobacter pylori Infected Gastric Biopsies in Korea
by: Moo-Sang CHONG, et al.
Published: (2025-06-01) -
Potential Unnecessity of Bismuth in Standard Triple Therapy for Clarithromycin-Susceptible Helicobacter pylori Infection
by: Seon Woo Oh, et al.
Published: (2025-03-01) -
Pathophysiology of Antibiotic Resistance: Clarithromycin
by: Diane E Taylor
Published: (2000-01-01) -
Helicobacter pylori: Primary Susceptibility to Clarithromycin in vitro in Nova Scotia
by: Linda M Best, et al.
Published: (1997-01-01) -
Eradication Rates of Clarithromycin Triple Therapy in Korea: A Systematic Review and Meta-analysis
by: Seung Joo Kang, et al.
Published: (2021-03-01)